Cyprus Institute of Neurology and Genetics (CING), was established in 1990, as a bi-communal, non-profit, private, academic, medical center.
Joined September 2012
- Tweets 5,182
- Following 364
- Followers 1,366
- Likes 515
1,725 Photos and videos
VACANCY for Post-Doctoral Fellow/Laboratory Scientific Officer
We are looking for a Post-Doctoral Fellow and/or a Laboratory Scientific Officer to join the Bioinformatics Department of the Cyprus Institute of Neurology and Genetics.
For more information:
cing.ac.cy/en/vacancies/may2…
1
1
70
Meet the speakers of the “Advancement of Treatments for Rare Diseases” Conference
Date: 16-17 June 2026
Location: CING
Discover the latest developments in rare disease research, innovation and patient access.
More information: cy2026rarediseases.com/
1
1
92
Meet the Speaker: @SKyriakidesEU, Former Commissioner for Health and Food Safety, European Commission
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 16-17 June 2026
More information: cy2026rarediseases.com/
1
2
80
Σημαντική επένδυση στην έρευνα: Νέα υποδομή στο ΙΝΓΚ για τη μελέτη του ενεργειακού μεταβολισμού.
Διαβάστε Περισσότερα:
cing.ac.cy/en/news-113/media…
1
78
Με χαρά φιλοξενήσαμε τον CEO της Alpha Bank Cyprus, κ. Μιλτιάδη Μιχαηλά & την Δ/ντρια Marketing & Δημοσίων Σχέσεων κα Έλενα Κων/νου Ριρή, στο ΙΝΓΚ.
Εκφράζουμε τις θερμές μας ευχαριστίες προς την Alpha Bank Cyprus για τη διαχρονική της στήριξη στην εκπαίδευση & την αριστεία.
1
2
142
Νέα εποχή για το ΙΝΓΚ – Παραδόθηκε & επίσημα το μεγαλύτερο αναπτυξιακό έργο από την ίδρυση του ΙΝΓΚ.
Πρόκειται για μια ουσιαστική επένδυση στο μέλλον της επιστήμης & της καινοτομίας, η οποία ενισχύει καθοριστικά την ερευνητική υποδομή & τη διεθνή ανταγωνιστικότητα του ΙΝΓΚ.
1
53
Meet the #CING Neuroimmunology Department.
Through basic, translational & clinical research, it studies immune mechanisms in the CNS, focusing on multiple sclerosis and advancing diagnostics & therapies.
🎥 Watch the video to learn more.
41
Meet the CING Bioinformatics Department.
By combining advanced computational approaches with artificial intelligence, the Department plays a key role in understanding disease mechanisms and advancing precision and personalised medicine.
🎥 Watch the video to learn more
2
71
In light of the latest developments &as a precautionary measure,the @CY2026EU has decided to postpone this week’s Presidency Conference.
Further information regarding new dates will be communicated in due course
We apologise for the inconvenience &thank you for your understanding
41
Meet the Speaker: Anne‑Sophie Lapointe, French representative in ERN Board of Member States
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: The Cyprus Institute of Neurology & Genetics Nicosia, Cyprus
cy2026rarediseases.com/
1
25
Meet the Speaker: Andri Papadopoulou, Scientific Officer, Joint Research Centre, European Commission
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: CING
More information: cy2026rarediseases.com/
22
Meet the Speaker: Marina Vasiliou, President and Managing Director, Biogen France
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: CING
More Information:
cy2026rarediseases.com/
24
NeurologyGeneticsCyp retweeted
Παγκόσμια Ημέρα Σπανίων Ασθενειών σήμερα και τα δύο βασικά ζητούμενα για τους ασθενείς παραμένουν η έγκαιρη διάγνωση και η αποτελεσματική θεραπεία. Συνεχίζουμε ακάθεκτοι να εργαζόμαστε ώστε να βελτιώνουμε συνεχώς την αντιμετώπισή τους.
#RareDiseaseDay
@NeuroGeneticsCy
1
4
63
We would like to inform you that registrations to attend the Conference“Advancement of Treatments for Rare Diseases”,which will take place on 5–6 March 2026 are now closed.
You may now register & join the conference virtually via live streaming by clicking cy2026rarediseases.com/live-…
1
34
Meet the Speaker: Dr. Christine Leopold, Assistant Professor, Drug Regulatory Science, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Science/WHO Collaborating Centre for Pharmaceutical Policy & Regulation
cy2026rarediseases.com/
30
Meet the Speaker: Nikolaos Zamboglou, Chief Executive Officer, German Oncology Center and the German Medical Institute
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: The CING, Nicosia, Cyprus
cy2026rarediseases.com/
1
28
Meet the Speaker: Prof.Alexis Arzimanoglou,ERN EpiCARE Coordinator, Director,Paediatric Epilepsy Dpt. University Children’s Hospital San Juan de Dios Barcelona
Join us at the “Advancement of Treatments for Rare Diseases”
Date:5–6 March 2026
Location:CING
cy2026rarediseases.com/
1
22
Meet the Speaker: Allan Byamukama, Executive Director, Founder, Byamukama Sickle Cell Foundation
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: The Cyprus Institute of Neurology & Genetics Nicosia, Cyprus
cy2026rarediseases.com/
1
1
35
Meet the Speaker: Maurizio Scarpa, Paediatrician and Director, Regional Coordinating Centre for Rare Diseases, University Hospital of Udine, Italy
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: The CING
cy2026rarediseases.com/
1
47
Meet the Speaker: Hélène Le Borgne, Policy Officer, European Commission
Join us at the “Advancement of Treatments for Rare Diseases”
Date: 5–6 March 2026
Location: The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus
More information: cy2026rarediseases.com/
1
1
42